Live Breaking News & Updates on Bio Announces Interim Results

Therini Bio Announces Interim Results from the Phase 1 Trial of THN391 for the Potential Treatment of Dementia
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United States , University Of California San Diego , University Of California San Francisco , Therini Bio , Jeffrey Stavenhagen , Leslie Schulze , Katerina Akassoglou , Eli Lilly , Clinical Development , Therini Bio Inc , Sv Health Investor Impact Medicine Fund , Boston Park Plaza Hotel , Ventures Fund , Dementia Discovery Fund , Alzheimer Drug Discovery Foundation , Bio Announces Interim Results , Potential Treatment , Clinical Trials , Chief Scientific Officer , Beyond Amyloid , Translation Studies , Novel Anti Fibrin Antibody , Poster Hall , Gladstone Institutes , California San Francisco , California San Diego ,